Position in ELAN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$152,601
-$197,236 QoQ
Shares Held
6,377
-58.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CENTAURUS FINANCIAL, INC. holds $2,456,588 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,227 | $1,211,637 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
6,621 | $502,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,507 | $296,352 | |
| 4 | ALKS |
Alkermes plc.
|
5,963 | $210,851 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
6,377 | $152,601 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
12,820 | $82,945 |
All Filings in ELAN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $152,601 | 6,377 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $349,837 | 15,459 | Shares | Sole | 2026-02-13 | |
| 2022-06-30 | $115,817 | 5,900 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $159,879 | 6,128 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $173,912 | 6,128 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $195,421 | 6,128 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $564,857 | 16,283 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $472,819 | 16,055 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $526,143 | 17,155 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $505,672 | 18,105 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $157,657 | 7,350 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||